These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2855185)

  • 21. Nutritional treatment of renal failure in type 1 diabetic nephropathy.
    Barsotti G; Ciardella F; Morelli E; Cupisti A; Mantovanelli A; Giovannetti S
    Clin Nephrol; 1988 Jun; 29(6):280-7. PubMed ID: 3396230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Sheveleva LA
    Ter Arkh; 1990; 62(9):91-7. PubMed ID: 2281418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1.
    Perna A; Ruggenenti P; Testa A; Spoto B; Benini R; Misefari V; Remuzzi G; Zoccali C
    Kidney Int; 2000 Jan; 57(1):274-81. PubMed ID: 10620209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CARI guidelines. Prevention of progression of kidney disease.
    Harris D; Thomas M; Johnson D; Nicholls K; Gillin A;
    Nephrology (Carlton); 2006 Apr; 11 Suppl 1():S2-197. PubMed ID: 16684077
    [No Abstract]   [Full Text] [Related]  

  • 25. Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
    Kanno Y; Takenaka T; Nakamura T; Suzuki H
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):730-7. PubMed ID: 17699280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L; Renke M; Rutkowski P; Rutkowski B; Lysiak-Szydłowska W
    Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-protein diet and glomerular size-selective function in membranous glomerulopathy.
    Remuzzi A; Perticucci E; Battaglia C; D'Amico G; Gentile MG; Remuzzi G
    Am J Kidney Dis; 1991 Mar; 17(3):317-22. PubMed ID: 1996576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
    Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
    N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
    Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Shchukina EV; Gaĭdukov VO; Gritsenko PV; Diadyk IA
    Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria.
    de Mello VD; Zelmanovitz T; Azevedo MJ; de Paula TP; Gross JL
    J Ren Nutr; 2008 Sep; 18(5):440-7. PubMed ID: 18721739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.
    Gansevoort RT; Heeg JE; Vriesendorp R; de Zeeuw D; de Jong PE
    Nephrol Dial Transplant; 1992; 7 Suppl 1():91-6. PubMed ID: 1337189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerular hypertension in the progression of chronic renal failure: role of low protein diet and angiotensin converting enzyme inhibitors.
    Cappelli P; Del Rosso G; Di Paolo B; Evangelista M; Albertazzi A
    Scand J Urol Nephrol Suppl; 1988; 108():25-30. PubMed ID: 3163827
    [No Abstract]   [Full Text] [Related]  

  • 36. [Present possibilities of treatment of primary chronic glomerulonephritis].
    Knotková V; Nĕmecek K
    Vnitr Lek; 1994 Jun; 40(6):345-8. PubMed ID: 8073642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
    Prasher PK; Varma PP; Baliga KV
    J Assoc Physicians India; 1999 Feb; 47(2):180-2. PubMed ID: 10999084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.
    Cruzado JM; Poveda R; Ibernón M; Díaz M; Fulladosa X; Carrera M; Torras J; Bestard O; Navarro I; Ballarín J; Romero R; Grinyó JM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3596-602. PubMed ID: 21393611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A protein-restricted diet combined with ACE inhibitors does not improve insulin sensitivity in renal hypertension].
    Spustová V; Stefiková K; Oksa A; Dzúrik R
    Vnitr Lek; 1996 Mar; 42(3):157-61. PubMed ID: 8686202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.
    Campbell R; Sangalli F; Perticucci E; Aros C; Viscarra C; Perna A; Remuzzi A; Bertocchi F; Fagiani L; Remuzzi G; Ruggenenti P
    Kidney Int; 2003 Mar; 63(3):1094-103. PubMed ID: 12631093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.